Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Tax-Related Share Withholding

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Summary

• On February 15, 2025, BioAtla, Inc. withheld 12,530 shares of common stock from Eric Sievers, the company's Chief Medical Officer.
• The shares were withheld to satisfy income tax and withholding obligations related to the vesting and net settlement of previously reported restricted stock units.
• The price per share for the withholding was $0.46.
• Following the transaction, Sievers beneficially owns 195,032 shares of BioAtla, Inc.
• The transaction was not a sale of shares by Sievers.

Sentiment

Score: 5

Explanation: This Form 4 filing is a routine disclosure of a tax-related transaction and has neutral sentiment. It doesn't indicate positive or negative news about the company's performance.

Industry Context

This is a standard procedure for companies to manage tax obligations related to employee stock compensation. It doesn't necessarily reflect the company's performance or outlook, but rather the mechanics of equity compensation.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the withholding of shares for tax purposes, which is a common practice.

Key Dates

Keywords

Form 4, BioAtla, BCAB, Eric Sievers, Chief Medical Officer, Share Withholding, Restricted Stock Units, Tax Obligations, Beneficial Ownership